Drug or treatment
Lebrikizumab clinical trials
As of November 12, 2026, Find a Trial lists 4 clinical trials of Lebrikizumab that are recruiting, at sites in 20 countries (most in Denmark (3), Germany (2), Argentina (1)). By phase: Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 20Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| How lebrikizumab affects the skin microbiome and mycobiome in adults with atopic dermatitis | — | Copenhagen | Recruiting | Sep 8, 2026 |
| Lebrikizumab for adults with nummular eczema | Phase 3 | Freiburg im Breisgau | Recruiting | Apr 21, 2026 |
| Evaluating the effects of lebrikizumab on well-being in adults with moderate-to-severe atopic dermatitis | — | Aarhus, Denmark | Recruiting | Feb 7, 2025 |
| Evaluating lebrikizumab for chronic rhinosinusitis with nasal polyps | Phase 3 | Birmingham, Alabama and 201 other locations | Recruiting | Apr 1, 2024 |
All recruiting trials (4)
-
How lebrikizumab affects the skin microbiome and mycobiome in adults with atopic dermatitis
This study looks at whether lebrikizumab changes the skin bacteria, fungi, and specifically Staphylococcus species, in adults with moderate-to-severe atopic dermatitis.
-
Lebrikizumab for adults with nummular eczema
This study tests whether lebrikizumab can help adults with nummular eczema who don’t respond well to topical steroids.
-
Evaluating the effects of lebrikizumab on well-being in adults with moderate-to-severe atopic dermatitis
This study is testing how the medication lebrikizumab affects the well-being and skin symptoms of adults with moderate-to-severe atopic dermatitis in everyday settings.
-
Evaluating lebrikizumab for chronic rhinosinusitis with nasal polyps
This study is testing a new drug called lebrikizumab to see if it can help adults with chronic rhinosinusitis and nasal polyps feel better while they are already using nasal sprays.
Quick answers
How many clinical trials of Lebrikizumab are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 20 countries. The most sites are in Denmark (3 trials), Germany (2 trials), Argentina (1 trial), Belgium (1 trial), Bulgaria (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.